Combined Shareholders’ Meeting of 24 May 2022

This article or press release has no online content. Please download the associated documents for more information.

Associated Documents

Preliminary-notice-to-the-Meeting-published-at-the-BALO-on-15-April-2022-Translation-for-information.pdf
Preliminary-notice-to-the-Meeting-published-at-the-BALO-on-15-April-2022-French-version-only.pdf
Report-of-the-Board-of-Directors-on-the-draft-resolutions-1.pdf
Universal-registration-document-2021-1.pdf

Understanding the true impact of living with FOP

Ipsen Announces Decision to Permanently Discontinue Distribution of NutropinAq® (somatropin) cartridges

Applications now open for the 2023 Golden Ticket Competition

Offering support to those impacted in Turkey & Syria

© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved - 2023